We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PRAX market cap is 1.56B. The company's latest EPS is USD -6.6144 and P/E is -12.62.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 468k | 515k | 431k | 357k | 302k |
| Operating Income | -25.52M | -27.81M | -41.89M | -37.49M | -56.84M |
| Net Income | -24.63M | -26.88M | -39.55M | -32.68M | -51.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 2.45M |
| Operating Income | -35.79M | -61.97M | -167.33M | -214.99M | -126.37M |
| Net Income | -40.68M | -70.32M | -167.06M | -214.03M | -123.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 106.73M | 87.95M | 250.41M | 441.06M | 416.26M |
| Total Liabilities | 19.97M | 18.28M | 20.73M | 21.96M | 33.59M |
| Total Equity | 86.76M | 69.67M | 229.68M | 419.1M | 382.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 47.69M | 303.18M | 292.75M | 115.13M | 87.95M |
| Total Liabilities | 7.58M | 15.72M | 41.94M | 39.02M | 18.28M |
| Total Equity | -81.01M | 287.46M | 250.81M | 76.11M | 69.67M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -87.28M | -111.14M | -20.86M | -48.14M | -75.64M |
| Investing | 39M | 38.95M | -91.22M | -287.14M | -237.58M |
| Financing | 87.75M | 91.87M | 182.76M | 399.12M | 400.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.42M | -52.62M | -124.55M | -185.04M | -111.14M |
| Investing | -103k | N/A | -140.52M | 96.89M | 38.95M |
| Financing | 60.39M | 304.42M | 107.59M | 10.47M | 91.87M |
| Market Cap | 1.56B |
| Price to Earnings Ratio | -12.62 |
| Price to Sales Ratio | 635.87 |
| Price to Cash Ratio | 19.14 |
| Price to Book Ratio | 22.34 |
| Dividend Yield | - |
| Shares Outstanding | 18.64M |
| Average Volume (1 week) | 330.17k |
| Average Volume (1 Month) | 364.54k |
| 52 Week Change | 108.67% |
| 52 Week High | 86.93 |
| 52 Week Low | 33.01 |
| Spread (Intraday) | 6.85 (7.98%) |
| Company Name | Praxis Precision Medicines Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.praxismedicines.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
